Life Sciences

Esperion’s New Cholesterol-Busting Drug Hits The Market

ANN ARBOR—After years of development, Nexletol, the new cholesterol-reducer from Ann Arbor’s Esperion Therapeutics Inc., is now on the market and available in pharmacies in the United States. Nexletol uses a new mechanism of action to reduce low-density lipoprotein (LDL-C), the so-called bad cholesterol in the bloodstream, the cholesterol that can cause arterial blockages that

Priority Health Expands Free Telehealth, Home Prescription Delivery

GRAND RAPIDS—In response to the COVID-19 outbreak, Priority Health announced that it will be expanding its existing $0 copay telehealth, also known as virtual care, to include all lines of business through April 30. This means that essentially all of the company’s nearly one million members across commercial, individual, Medicaid and Medicare plans, will now

By |2020-03-29T17:38:30-04:00March 29th, 2020|ESD, IoT, Life Sciences, Life Sciences/Biotech|

Automation Alley Seeks Help From Medical Device Makers Battling COVID-19

TROY—Automation Alley is requesting help from its members identifying suppliers and providers of personal protective equipment and medical supplies in response to the coronavirus pandemic. The survey is sponsored by the National Council of Textile Organization, the Industrial Fabrics Association International, and the Association of the Nonwoven Fabrics Industry. The survey is intended to identify

Esperion Names Pharma CFO To Board

ANN ARBOR—Cholesterol-lowering drug developer Esperino Therapeutics Inc. has appointed Alan Fuhrman as a Class III director, with a term expiring at the 2022 meeting of stockholders. “On behalf of the Lipid Management team and our directors, I am very pleased to welcome Alan to the Esperion board. His extensive financial leadership experience will be extremely

By |2020-03-22T16:02:44-04:00March 22nd, 2020|Life Sciences, Life Sciences/Biotech|

Two Traverse City Companies Team Up To Provide Drive-Through COVID19 Testing Popups

TRAVERSE CITY – Two Traverse City companies are working together to offer drive-through COVID-19 testing centers that would include the tent to house staff and the software that would facilitate testing and samples that would be sent to laboratories to determine if the person tested has coronavirus. Russell Schindler, CEO of SampleServe, has spent more

By |2020-03-18T14:46:17-04:00March 18th, 2020|Featured, Life Sciences, Life Sciences/Biotech|

Coronavirus: Amazon Suspends All Warehouse Shipments Except Medical Supplies, High-Demand Products

SEATTLE - Amazon has temporarily suspended the shipment of all items from independent merchants to its warehouses that are not medical supplies or “high-demand” products. This temporary suspension will go through 5 April as the e-commerce giant prioritises products relating to combating the growing coronavirus pandemic. “We are temporarily prioritising household staples, medical supplies and other high-demand

By |2020-03-17T18:28:35-04:00March 17th, 2020|Featured, Life Sciences, Life Sciences/Biotech|

Study: 1 in 6 American Workers Could Be Negatively Impacted By Social Distancing

MUNCIE, Indiana – About 1 in 6 workers, or about 17 percent of U.S. employees, could be negatively impacted if social distancing becomes the norm as the nation attempts to contain COVID-19, says a new Ball State University report. “Occupational Exposure to Social Distancing: A Preliminary Analysis Using O*NET Data,” an analysis by Ball State’s

By |2020-03-18T07:41:42-04:00March 16th, 2020|Life Sciences, Life Sciences/Biotech|

Michigan Schools Scramble To Plan For Potential Coronavirus Outbreak

ANN ARBOR - Michigan schools are scrambling to build plans for what to do if a student or community member is diagnosed with the potentially deadly new coronavirus. School districts around the state are meeting with county health departments and preparing protocols that address everything from potential school closures to continuing school through online services

By |2020-02-28T08:24:56-05:00February 28th, 2020|Featured, Life Sciences|

Another Step Toward European OK For Esperion Cholesterol Drugs

ANN ARBOR—Esperion Therapeutics Inc. has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a “positive opinion” for both its bempedoic acid and its benpedoic acid-ezetimibe tablets to treat high cholesterol and other risky conditions involving lipids in the bloodstream. Company officials said the committee “found there were no

By |2020-02-02T20:13:47-05:00February 2nd, 2020|ESD, Life Sciences|

XLerateHealth Partners With U-M to Bring Biomedical Commercialization Program to Flint

FLINT - XLerateHealth, a Louisville, KY-based healthcare startup accelerator, has partnered with the University of Michigan to bring its Fast Forward Medical Innovation’s fastPACE biomedical entrepreneur program to XLH Flint. FFMI fastPACE is a four-week biomedical innovation and commercialization project-based course designed for life science innovators with an early stage project. More than 250 project